Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-03-09 @ 9:20 AM
Study NCT ID:
NCT00083759
Status:
TERMINATED
Last Update Posted:
2016-07-18
First Post:
2004-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate
Sponsor:
Biogen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ELN100226-RA201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |